文献速递肝病

三维生物打印肝组织类器官延长肝衰竭小鼠生存期

Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure.
PubMed 文献 · Gut · 2020-05-20

该研究利用HepaRG细胞与生物墨水构建三维生物打印肝类器官(3DP-HOs),体外分化7天后检测到白蛋白分泌、药物代谢和糖原储存等肝功能。将3DP-HOs移植到Fah缺陷肝损伤小鼠腹腔后,类器官进一步成熟并形成功能性血管系统,小鼠获得人特异性药物代谢活性,且移植显著改善了小鼠生存。

要点

  • 3DP-HOs体外分化7天后具备白蛋白分泌、药物代谢和糖原储存等肝功能。
  • 移植到Fah-/-Rag2-/-小鼠腹腔后,3DP-HOs成熟并形成功能性血管系统。
  • 移植3DP-HOs显著改善肝损伤小鼠生存,并赋予人特异性药物代谢活性。

核心结论

  • 三维生物打印肝类器官模型具有体内肝功能,移植后可缓解肝衰竭并延长小鼠生存。

研究设计与样本

  • 使用HepaRG细胞和生物墨水按特定3D打印流程构建3DP-HOs,体外分化7天后移植到Fah缺陷小鼠。

主要发现

  • 3DP-HOs体外分化7天后广泛获得白蛋白分泌、药物代谢和糖原储存等肝功能。
  • 移植到Fah-/-Rag2-/-肝损伤小鼠腹腔后,3DP-HOs进一步成熟并增加肝特异性蛋白合成。
  • 移植小鼠获得人特异性药物代谢活性,移植的3DP-HOs内形成功能性血管系统。
  • 移植3DP-HOs显著改善了小鼠生存。

临床怎么用

  • 3D生物打印肝组织有望作为替代移植供体用于肝衰竭治疗,但尚需进一步临床前验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Shortage of organ donors, a critical challenge for treatment of end-stage organ failure, has motivated the development of alternative strategies to generate organs in vitro. Here, we aim to describe the hepatorganoids, which is a liver tissue model generated by three-dimensional (3D) bioprinting of HepaRG cells and investigate its liver functions in vitro and in vivo. DESIGN: 3D bioprinted hepatorganoids (3DP-HOs) were constructed using HepaRG cells and bioink, according to specific 3D printing procedures. Liver functions of 3DP-HOs were detected after 7 days of differentiation in vitro, which were later transplanted into Fah-deficient mice. The in vivo liver functions of 3DP-HOs were evaluated by survival time and liver damage of mice, human liver function markers and human-specific debrisoquine metabolite production. RESULTS: 3DP-HOs broadly acquired liver functions, such as ALBUMIN secretion, drug metabolism and glycogen storage after 7 days of differentiation. After transplantation into abdominal cavity of Fah-/-Rag2-/- mouse model of liver injury, 3DP-HOs further matured and displayed increased synthesis of liver-specific proteins. Particularly, the mice acquired human-specific drug metabolism activities. Functional vascular systems were also formed in transplanted 3DP-HOs, further enhancing the material transport and liver functions of 3DP-HOs. Most importantly, transplantation of 3DP-HOs significantly improved the survival of mice. CONCLUSIONS: Our results demonstrated a comprehensive proof of principle, which indicated that 3DP-HO model of liver tissues possessed in vivo hepatic functions and alleviated liver failure after transplantation, suggesting that 3D bioprinting could be used to generate human liver tissues as the alternative transplantation donors for treatment of liver diseases.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Yang H, Sun L, Pang Y, et al. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut. 2020. PMID: 32434830. doi:10.1136/gutjnl-2019-319960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。